Allied Market Research
Liver Cirrhosis Treatment Market

Liver Cirrhosis Treatment Market

Size, Share, Competitive Landscape and Trend Analysis Report by Disease Type (Alcoholic Cirrhosis, Atrophic Cirrhosis, Biliary Cirrhosis, Cryptogenic Cirrhosis), by Treatment Type (Immunosuppressants, Antibiotics, Vaccines, Anti-viral drugs, Corticosteroids) and by End User (Hospital Pharmacy  , Retail Pharmacy, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A12599
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


The liver performs vital activities  in the body, including protein synthesis, lipid and glucose metabolism, and detoxification of drugs, alcohol, and environmental toxins. Liver disease is a broad term that covers all the potential problems that are caused due to liver failure to execute its intended function. Different types of liver diseases are hepatitis, cirrhosis, liver cancer, and liver abscess (collection of pus).

Liver cirrhosis is a late stage of scarring caused by liver disease and conditions such as chronic alcoholism, hepatitis, and non-alcoholic fatty liver disease. Signs and symptoms of liver cirrhosis include abdominal pain, fatigue, intestinal bleeding, jaundice, weakness, and weight loss. Liver cirrhosis can be broadly classified into hepatitis C-related cirrhosis, alcoholic cirrhosis, primary sclerosing cholangitis, and primary biliary cirrhosis. Approximately 20% to 30% of the people who are chronically infected with the hepatitis C virus are likely to develop liver cirrhosis in the next 15 to 25 years.. Alcoholic cirrhosis is a severe  form of liver disease caused by excessive alcohol consumption. About 10% to 15% of people with alcoholism develop liver cirrhosis. Liver cirrhosis cannot be reversed; although if diagnosed earlier, it  can be treated, and further damage can be avoided.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that first emerged in late December in the Hubei province of the Wuhan city in China. The virus that causes , severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is highly infectious and is transmitted from person to person. The disease has spread to almost 213 countries across the globe ever since its outbreak in December 2019, compelling the World Health Organization to declare it a pandemic on March 11, 2020.

Coronavirus disease 2019 (COVID-19) has caused an economic crisis along with the healthcare crisis. The COVID-19 pandemic has stretched the global healthcare system and ; developed countries are anticipated to experience an economic recession as a result. The pandemic has had an adverse impact on the healthcare system, with revenue dropping by a 50% to 70% drop since March. Several small hospitals, clinics, and nursing homes, have been forced to shut their operations. Furthermore, social distancing and localized curfews have resulted in delayed elective surgical procedures. Moreover, visa cancellations have disrupted medical tourism and can negatively impact the growth of the healthcare services market..

COVID-19 has post -recovery effects on many organs, including the liver and may induce cirrhosis and other liver disease as a result of viral infection, which is expected to drive the  market growth during the forecast period.

Top Impacting Factors

Factors such as rise in prevalence of liver diseases, increase in geriatric population, and surge in R&D activities to develop innovative products contribute toward the market growth. Furthermore, the availability of generic and biosimilar drugs as well as sedentary lifestyles such as increased consumption of alcohol, unhealthy diets are expected to make way for different opportunities for the liver cirrhosis treatment market..

The global liver cirrhosis treatment market is expected to be driven by increase in awareness initiatives and rise in R&D investment for the development of new drug molecules in the near future. However, the high cost of drug development and stringent government regulations are expected to hinder the market growth during the forecast period.

Key Market Trends

The phase II trial of IDN-6556 (emricasan) is underway on liver cirrhosis subjects. , Zydus Cadila received approval from the Drug Controller General of India (DCGI) in December 2020 for their new drug application for Saroglitazar to treat a particular condition of liver, commonly known as NASH in India.

According to the Centers for Disease Control and Prevention, the global incidence of liver disease was 3.9 million in 2016. According to the World Health Organization (WHO), there is an increase in incidence of liver cirrhosis in countries in Europe due to high consumption of alcohol.

Key Benefits of the Report

  • This study presents the analytical depiction of the liver cirrhosis treatment market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the liver cirrhosis treatment market share.
  • The current market is quantitatively analyzed to highlight the growth scenario of the Liver cirrhosis treatment market.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and the competition that will take shape in the upcoming years.

Questions Answered in the Liver Cirrhosis Treatment Market Report

  • Who are the leading market players active in the liver cirrhosis treatment market?
  • How does each segment of the market is expected to grow during the forecast period?
  • What are the adoption trends for the liver cirrhosis treatment market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What are the future projections that would help in taking further strategic steps?
  • What are the impacts of the COVID-19 in the industry?
  • What is liver cirrhosis?
  • What is the prediction of the liver cirrhosis treatment market in the future?
  • What are the current and predicted trends?

Liver Cirrhosis Treatment Market Report Highlights

Aspects Details
By Disease Type
  • Alcoholic Cirrhosis
  • Atrophic Cirrhosis
  • Biliary Cirrhosis
  • Cryptogenic Cirrhosis
By Treatment Type
  • Immunosuppressants
  • Antibiotics
  • Vaccines
  • Anti-viral drugs
  • Corticosteroids
By End User
  • Hospital Pharmacy  
  • Retail Pharmacy
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Liver Cirrhosis Treatment Market

Start reading.
This Report and over 71,223+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690  $3,321
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930  $3,537
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820  $4,947
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540  $5,559
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870  $7,896
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports
*Terms and Conditions Apply

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save the time of readers